Danielle Benoit Ph.D. is the Department Chair and Professor of Biomedical Engineering at the University Oregon. Her research focuses on the development of therapeutic biomaterials with tunable degradation and mechanical properties for regenerative medicine needs. She has expertise in polymer synthesis and nanoparticle design for drug delivery and tissue engineering applications. She works on the development of salivary gland tissue chips using Nidus MBATM for radio protective drug discovery. She brings expertise in the development of Nidus technology for applications in tissue chip and organoid culture for HTS screening.
Benjamin Miller, Ph.D. Is a Professor at the University of Rochester in the Department of Dermatology with secondary appointments in Biomedical Engineering, Biochemistry and Biophysics. His Lab studies biomolecular interactions through the synthesis of molecular probes and through the development of novel optical sensing technologies. He pioneered the development of arrayed imaging reflectometry (AIR) that was licensed to Adara BioSystems for multiplex detection of pathogens and immune markers. He also is co-founder of Phlotonics that commercializes optical technologies for real-time monitoring of bioprocesses and.
Michael R. King Ph.D. is the J. Lawrence E.D. Butcher Chair of Bioengineering at Rice University. He is also the Chair of the Biomedical Engineering and a Professor of Radiology and Radiological Sciences. He is a fellow of the American Institute for Medical and Biological Engineering and of the Biomedical Engineering Society. The King Lab studies receptor-mediated adhesion of circulating cells, and has developed computational and in vitro models to study the function of leukocytes, platelets, stem and circulating tumor cells under flow. Dr. King brings expertise in application of Nidus technology to cancer research.
James McGrath Ph.D. is a professor in the Biomedical Engineering Department at the University of Rochester. He leads the Nanomembrane Research Group that develops applications using ultrathin (15 nm – 400 nm) porous materials fabricated using silicon-base manufacturing. He is a co-founder of SiMPore Inc. that has commercialized this technology. Dr. McGrath brings expertise in microfluidics, silicon-based engineering and know how in developing novel devices.
